2021 Q4 Form 10-K Financial Statement

#000162828022003825 Filed on February 24, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $4.079B $17.66B $3.159B
YoY Change 29.11% 85.95% 140.52%
Cost Of Revenue $2.896B $13.24B $2.355B
YoY Change 22.98% 95.76% 199.5%
Gross Profit $1.182B $4.420B $803.7M
YoY Change 47.08% 61.7% 52.5%
Gross Profit Margin 28.98% 25.03% 25.44%
Selling, General & Admin $783.7M $2.601B $488.0M
YoY Change 60.59% 53.98% 60.84%
% of Gross Profit 66.3% 58.84% 60.72%
Research & Development $395.8M $1.399B $253.4M
YoY Change 56.21% 57.97% 46.22%
% of Gross Profit 33.49% 31.65% 31.53%
Depreciation & Amortization $39.05M $134.8M $22.50M
YoY Change 73.56% 60.02% 20.32%
% of Gross Profit 3.3% 3.05% 2.8%
Operating Expenses $1.180B $4.000B $742.5M
YoY Change 58.86% 55.35% 55.5%
Operating Profit $2.503M $161.1M $61.20M
YoY Change -95.91% -956.3% 23.64%
Interest Expense -$18.51M $58.10M $256.3M
YoY Change -107.22% -22.74% -13589.47%
% of Operating Profit -739.63% 36.06% 418.79%
Other Income/Expense, Net -$1.260M $29.47M -$3.100M
YoY Change -59.35% -89.9% -219.23%
Pretax Income -$74.39M $157.5M $298.4M
YoY Change -124.93% -27.09% -23.76%
Income Tax $6.597M -$1.364M $4.400M
% Of Pretax Income -0.87% 1.47%
Net Earnings -$76.83M $166.3M $294.0M
YoY Change -126.13% -21.97% -24.79%
Net Earnings / Revenue -1.88% 0.94% 9.31%
Basic Earnings Per Share $0.36
Diluted Earnings Per Share -$166.1K $0.33 $482.7K
COMMON SHARES
Basic Shares Outstanding 458.4M shares
Diluted Shares Outstanding 501.8M shares

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.313B $5.313B $3.853B
YoY Change 37.89% 37.88% 150.28%
Cash & Equivalents $4.444B $4.444B $3.158B
Short-Term Investments $869.3M $869.3M $695.1M
Other Short-Term Assets $687.4M $4.741B $383.1M
YoY Change 79.45% 80.15% 52.98%
Inventory $77.06M $77.06M $61.13M
Prepaid Expenses $63.34M $34.28M
Receivables $89.70M $1.261B $41.96M
Other Receivables $228.9M $228.9M $148.0M
Total Short-Term Assets $11.62B $11.62B $7.762B
YoY Change 49.73% 49.73% 141.06%
LONG-TERM ASSETS
Property, Plant & Equipment $282.1M $731.5M $233.5M
YoY Change 20.82% 5.96% 56.52%
Goodwill $519.3M $316.7M
YoY Change 63.96% 18.91%
Intangibles
YoY Change
Long-Term Investments $1.757B $1.757B $923.0M
YoY Change 90.4% 90.46% 42.66%
Other Assets $370.5M $139.6M $499.3M
YoY Change -25.78% 244.73% 154.22%
Total Long-Term Assets $3.405B $3.405B $2.108B
YoY Change 61.53% 61.52% 58.32%
TOTAL ASSETS
Total Short-Term Assets $11.62B $11.62B $7.762B
Total Long-Term Assets $3.405B $3.405B $2.108B
Total Assets $15.03B $15.03B $9.870B
YoY Change 52.25% 52.25% 116.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $82.17M $82.17M $47.09M
YoY Change 74.51% 74.46% 11.81%
Accrued Expenses $254.9M $427.7M $126.7M
YoY Change 101.17% 60.19% -1.31%
Deferred Revenue $48.46M $44.91M
YoY Change 7.91% 17.86%
Short-Term Debt $497.5M $497.5M $464.0M
YoY Change 7.23% 7.2%
Long-Term Debt Due $455.0K $455.0K $0.00
YoY Change
Total Short-Term Liabilities $6.536B $6.536B $4.126B
YoY Change 58.4% 58.4% 143.56%
LONG-TERM LIABILITIES
Long-Term Debt $4.559B $4.559B $2.587B
YoY Change 76.24% 76.24% 175.55%
Other Long-Term Liabilities $207.6M $602.6M $85.29M
YoY Change 143.41% 26.87% -9.71%
Total Long-Term Liabilities $4.767B $5.162B $2.672B
YoY Change 78.38% 68.58% 158.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.536B $6.536B $4.126B
Total Long-Term Liabilities $4.767B $5.162B $2.672B
Total Liabilities $11.71B $11.75B $7.188B
YoY Change 62.95% 63.52% 153.44%
SHAREHOLDERS EQUITY
Retained Earnings -$27.97M -$297.2M
YoY Change -90.59% -41.76%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.273B $3.273B $2.682B
YoY Change
Total Liabilities & Shareholders Equity $15.03B $15.03B $9.870B
YoY Change 52.25% 52.25% 116.85%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$76.83M $166.3M $294.0M
YoY Change -126.13% -21.97% -24.79%
Depreciation, Depletion And Amortization $39.05M $134.8M $22.50M
YoY Change 73.56% 60.02% 20.32%
Cash From Operating Activities $175.1M $847.8M $120.7M
YoY Change 45.03% 389.76% 97.55%
INVESTING ACTIVITIES
Capital Expenditures -$36.29M $134.3M -$52.00M
YoY Change -30.21% -2.95% 211.38%
Acquisitions $164.0M
YoY Change 106.98%
Other Investing Activities -$17.97M -$1.007B -$22.80M
YoY Change -21.19% 114.98% -105.58%
Cash From Investing Activities -$54.26M -$1.311B -$74.90M
YoY Change -27.56% 116.09% -119.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 653.3M $2.652B 983.8M
YoY Change -33.59% -27.87% -7846.46%
NET CHANGE
Cash From Operating Activities 175.1M $847.8M 120.7M
Cash From Investing Activities -54.26M -$1.311B -74.90M
Cash From Financing Activities 653.3M $2.652B 983.8M
Net Change In Cash 774.1M $2.182B 1.030B
YoY Change -24.82% -32.99% 133.84%
FREE CASH FLOW
Cash From Operating Activities $175.1M $847.8M $120.7M
Capital Expenditures -$36.29M $134.3M -$52.00M
Free Cash Flow $211.3M $713.5M $172.7M
YoY Change 22.38% 1955.75% 121.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001512673
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2020 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member
CY2021 sq Customer Advancesand Deposits Periodfor Settlement
CustomerAdvancesandDepositsPeriodforSettlement
P1D
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-37622
CY2021 dei Entity Registrant Name
EntityRegistrantName
BLOCK, INC.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
80-0429876
CY2021 dei City Area Code
CityAreaCode
415
CY2021 dei Local Phone Number
LocalPhoneNumber
375-3176
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Security12b Title
Security12bTitle
Class A Common Stock, $0.0000001 par value per share
CY2021 dei Trading Symbol
TradingSymbol
SQ
CY2021 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
95200000000 USD
CY2021 dei Auditor Firm
AuditorFirmId
42
CY2021 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2021 dei Auditor Location
AuditorLocation
San Francisco, California
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4443669000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3158058000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
869283000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
695112000 USD
CY2021Q4 us-gaap Settlement Assets Current
SettlementAssetsCurrent
1171612000 USD
CY2020Q4 us-gaap Settlement Assets Current
SettlementAssetsCurrent
1024895000 USD
CY2021Q4 us-gaap Customer Funds
CustomerFunds
2830995000 USD
CY2020Q4 us-gaap Customer Funds
CustomerFunds
2037832000 USD
CY2021Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
517940000 USD
CY2020Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
462665000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
687429000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
383067000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
10520928000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
7761629000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
282140000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
233520000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
519276000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
316701000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
257049000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
137612000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
1526430000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
463950000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
449406000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
456888000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
370535000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
499250000 USD
CY2021Q4 us-gaap Assets
Assets
13925764000 USD
CY2020Q4 us-gaap Assets
Assets
9869550000 USD
CY2021Q4 srt Payables To Customers
PayablesToCustomers
3979624000 USD
CY2020Q4 srt Payables To Customers
PayablesToCustomers
3009051000 USD
CY2021Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
254611000 USD
CY2020Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
239362000 USD
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
639309000 USD
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
360850000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
64027000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
52747000 USD
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
497533000 USD
CY2020Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
464094000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5435104000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4126104000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4559208000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2586924000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
395017000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
389662000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
222846000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
85291000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
10612175000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
7187981000 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0000001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0000001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3317255000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2955464000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16435000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
23328000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27965000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-297223000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3272855000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2681569000 USD
CY2021Q4 us-gaap Minority Interest
MinorityInterest
40734000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
0 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3313589000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2681569000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13925764000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9869550000 USD
CY2021 us-gaap Revenues
Revenues
17661203000 USD
CY2020 us-gaap Revenues
Revenues
9497578000 USD
CY2019 us-gaap Revenues
Revenues
4713500000 USD
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
13241380000 USD
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
6764169000 USD
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
2823815000 USD
CY2021 us-gaap Gross Profit
GrossProfit
4419823000 USD
CY2020 us-gaap Gross Profit
GrossProfit
2733409000 USD
CY2019 us-gaap Gross Profit
GrossProfit
1889685000 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1399079000 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
885681000 USD
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
674165000 USD
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1617189000 USD
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1109670000 USD
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
625126000 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
983326000 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
579203000 USD
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
436878000 USD
CY2021 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
187991000 USD
CY2020 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
177670000 USD
CY2019 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
126959000 USD
CY2021 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
71126000 USD
CY2020 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2019 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
4258711000 USD
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
2752224000 USD
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
1863128000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
161112000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-18815000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
26557000 USD
CY2021 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 USD
CY2020 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 USD
CY2019 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
373445000 USD
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-33124000 USD
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-56943000 USD
CY2019 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-21516000 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
29474000 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
291725000 USD
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-273000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
157462000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
215967000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
378213000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1364000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2862000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2767000 USD
CY2021 us-gaap Profit Loss
ProfitLoss
158826000 USD
CY2020 us-gaap Profit Loss
ProfitLoss
213105000 USD
CY2019 us-gaap Profit Loss
ProfitLoss
375446000 USD
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-7458000 USD
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
166284000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
213105000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
375446000 USD
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
458432000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
443126000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
424999000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
501779000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
482167000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
466076000 shares
CY2021 us-gaap Profit Loss
ProfitLoss
158826000 USD
CY2020 us-gaap Profit Loss
ProfitLoss
213105000 USD
CY2019 us-gaap Profit Loss
ProfitLoss
375446000 USD
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-24667000 USD
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
20439000 USD
CY2019 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1879000 USD
CY2021 us-gaap Adjustment For Long Term Intercompany Transactions Net Of Tax
AdjustmentForLongTermIntercompanyTransactionsNetOfTax
0 USD
CY2020 us-gaap Adjustment For Long Term Intercompany Transactions Net Of Tax
AdjustmentForLongTermIntercompanyTransactionsNetOfTax
0 USD
CY2019 us-gaap Adjustment For Long Term Intercompany Transactions Net Of Tax
AdjustmentForLongTermIntercompanyTransactionsNetOfTax
75000 USD
CY2021 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-15096000 USD
CY2020 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
1260000 USD
CY2019 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
5728000 USD
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
119063000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
234804000 USD
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
383128000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1120501000 USD
CY2019 us-gaap Profit Loss
ProfitLoss
375446000 USD
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
118550000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7682000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
306201000 USD
CY2019 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
212264000 USD
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3000 USD
CY2019 sq Adjustments Related To Recovery Of Shares Issued And Withheld For Indemnification Purposes
AdjustmentsRelatedToRecoveryOfSharesIssuedAndWithheldForIndemnificationPurposes
1069000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1715050000 USD
CY2020 us-gaap Profit Loss
ProfitLoss
213105000 USD
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
161984000 USD
CY2020 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
35319000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
21699000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
411673000 USD
CY2020 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
314019000 USD
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
195749000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2681569000 USD
CY2021 us-gaap Profit Loss
ProfitLoss
158826000 USD
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
126829000 USD
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
28735000 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-39763000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
623067000 USD
CY2021 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
323012000 USD
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
408879000 USD
CY2021 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
48192000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3313589000 USD
CY2021 us-gaap Profit Loss
ProfitLoss
158826000 USD
CY2020 us-gaap Profit Loss
ProfitLoss
213105000 USD
CY2019 us-gaap Profit Loss
ProfitLoss
375446000 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
134757000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
84212000 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
75598000 USD
CY2021 sq Noncash Interestand Other Expense
NoncashInterestandOtherExpense
31104000 USD
CY2020 sq Noncash Interestand Other Expense
NoncashInterestandOtherExpense
76129000 USD
CY2019 sq Noncash Interestand Other Expense
NoncashInterestandOtherExpense
33478000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6651000 USD
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021 sq Noncash Lease Related Costs
NoncashLeaseRelatedCosts
83137000 USD
CY2020 sq Noncash Lease Related Costs
NoncashLeaseRelatedCosts
70253000 USD
CY2019 sq Noncash Lease Related Costs
NoncashLeaseRelatedCosts
29696000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
608040000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
397800000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
297863000 USD
CY2021 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 USD
CY2020 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 USD
CY2019 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
373445000 USD
CY2021 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
35492000 USD
CY2020 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
295297000 USD
CY2019 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-12326000 USD
CY2021 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
187991000 USD
CY2020 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
177670000 USD
CY2019 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
126959000 USD
CY2021 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
71126000 USD
CY2020 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2019 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10435000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-8016000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1376000 USD
CY2021 sq Increase Decreasein Settlement Assets
IncreaseDecreaseinSettlementAssets
346217000 USD
CY2020 sq Increase Decreasein Settlement Assets
IncreaseDecreaseinSettlementAssets
547484000 USD
CY2019 sq Increase Decreasein Settlement Assets
IncreaseDecreaseinSettlementAssets
326596000 USD
CY2021 sq Payments For Origination And Purchases Of Loans
PaymentsForOriginationAndPurchasesOfLoans
3227172000 USD
CY2020 sq Payments For Origination And Purchases Of Loans
PaymentsForOriginationAndPurchasesOfLoans
1837137000 USD
CY2019 sq Payments For Origination And Purchases Of Loans
PaymentsForOriginationAndPurchasesOfLoans
2266738000 USD
CY2021 sq Proceeds From Sale Collection And Forgiveness Of Loans
ProceedsFromSaleCollectionAndForgivenessOfLoans
3067344000 USD
CY2020 sq Proceeds From Sale Collection And Forgiveness Of Loans
ProceedsFromSaleCollectionAndForgivenessOfLoans
1505406000 USD
CY2019 sq Proceeds From Sale Collection And Forgiveness Of Loans
ProceedsFromSaleCollectionAndForgivenessOfLoans
2168682000 USD
CY2021 us-gaap Increase Decrease In Payables To Customers
IncreaseDecreaseInPayablesToCustomers
171555000 USD
CY2020 us-gaap Increase Decrease In Payables To Customers
IncreaseDecreaseInPayablesToCustomers
371598000 USD
CY2019 us-gaap Increase Decrease In Payables To Customers
IncreaseDecreaseInPayablesToCustomers
181520000 USD
CY2021 sq Increase Decreasein Settlement Liabilities Current
IncreaseDecreaseinSettlementLiabilitiesCurrent
15249000 USD
CY2020 sq Increase Decreasein Settlement Liabilities Current
IncreaseDecreaseinSettlementLiabilitiesCurrent
143528000 USD
CY2019 sq Increase Decreasein Settlement Liabilities Current
IncreaseDecreaseinSettlementLiabilitiesCurrent
41697000 USD
CY2021 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
61983000 USD
CY2020 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
185308000 USD
CY2019 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
47480000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
847830000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
173110000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
327630000 USD
CY2021 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
2714560000 USD
CY2020 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
1322362000 USD
CY2019 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
992583000 USD
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
831019000 USD
CY2020 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
607134000 USD
CY2019 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
430888000 USD
CY2021 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
617097000 USD
CY2020 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
585427000 USD
CY2019 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
548619000 USD
CY2021 sq Paymentsto Acquire Debt Securities Availableforsale Customer Funds
PaymentstoAcquireDebtSecuritiesAvailableforsaleCustomerFunds
488851000 USD
CY2020 sq Paymentsto Acquire Debt Securities Availableforsale Customer Funds
PaymentstoAcquireDebtSecuritiesAvailableforsaleCustomerFunds
642252000 USD
CY2019 sq Paymentsto Acquire Debt Securities Availableforsale Customer Funds
PaymentstoAcquireDebtSecuritiesAvailableforsaleCustomerFunds
311499000 USD
CY2021 sq Proceeds From Maturities Of Debt Securities Available For Sale Customer Funds
ProceedsFromMaturitiesOfDebtSecuritiesAvailableForSaleCustomerFunds
505501000 USD
CY2020 sq Proceeds From Maturities Of Debt Securities Available For Sale Customer Funds
ProceedsFromMaturitiesOfDebtSecuritiesAvailableForSaleCustomerFunds
382887000 USD
CY2019 sq Proceeds From Maturities Of Debt Securities Available For Sale Customer Funds
ProceedsFromMaturitiesOfDebtSecuritiesAvailableForSaleCustomerFunds
158055000 USD
CY2021 sq Proceedsfrom Saleof Debt Securities Availableforsale Customer Funds
ProceedsfromSaleofDebtSecuritiesAvailableforsaleCustomerFunds
35071000 USD
CY2020 sq Proceedsfrom Saleof Debt Securities Availableforsale Customer Funds
ProceedsfromSaleofDebtSecuritiesAvailableforsaleCustomerFunds
51430000 USD
CY2019 sq Proceedsfrom Saleof Debt Securities Availableforsale Customer Funds
ProceedsfromSaleofDebtSecuritiesAvailableforsaleCustomerFunds
17493000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
134320000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
138402000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
62498000 USD
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
170000000 USD
CY2020 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
50000000 USD
CY2019 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2021 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
48510000 USD
CY2020 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
1277000 USD
CY2019 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
15250000 USD
CY2021 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
420644000 USD
CY2020 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
0 USD
CY2019 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
33016000 USD
CY2021 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
CY2020 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
CY2019 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
309324000 USD
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
163970000 USD
CY2020 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
79221000 USD
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
20372000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1310879000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-606636000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
95193000 USD
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2116544000 USD
CY2019 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2021 us-gaap Payments For Hedge Financing Activities
PaymentsForHedgeFinancingActivities
0 USD
CY2020 us-gaap Payments For Hedge Financing Activities
PaymentsForHedgeFinancingActivities
338145000 USD
CY2019 us-gaap Payments For Hedge Financing Activities
PaymentsForHedgeFinancingActivities
0 USD
CY2021 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 USD
CY2020 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
232095000 USD
CY2019 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 USD
CY2021 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
1971828000 USD
CY2020 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
CY2019 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
CY2021 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
681539000 USD
CY2020 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
464094000 USD
CY2019 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
648100000 USD
CY2020 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2019 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
126719000 USD
CY2020 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
161985000 USD
CY2019 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
118514000 USD
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
323011000 USD
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
314019000 USD
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
212264000 USD
CY2021 us-gaap Net Change Interest Bearing Deposits Domestic
NetChangeInterestBearingDepositsDomestic
59844000 USD
CY2020 us-gaap Net Change Interest Bearing Deposits Domestic
NetChangeInterestBearingDepositsDomestic
0 USD
CY2019 us-gaap Net Change Interest Bearing Deposits Domestic
NetChangeInterestBearingDepositsDomestic
0 USD
CY2021 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-9948000 USD
CY2020 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-7359000 USD
CY2019 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-5124000 USD
CY2021 sq Proceeds From Customer Funds Restricted From Use
ProceedsFromCustomerFundsRestrictedFromUse
793163000 USD
CY2020 sq Proceeds From Customer Funds Restricted From Use
ProceedsFromCustomerFundsRestrictedFromUse
1361540000 USD
CY2019 sq Proceeds From Customer Funds Restricted From Use
ProceedsFromCustomerFundsRestrictedFromUse
342275000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2652034000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3676735000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
243401000 USD
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-7066000 USD
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12995000 USD
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3841000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2181919000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3256204000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
670065000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4793171000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1536967000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
866902000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6975090000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4793171000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1536967000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4443669000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3158058000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1047118000 USD
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
18778000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
30279000 USD
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
38873000 USD
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
71702000 USD
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
13526000 USD
CY2019Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
12715000 USD
CY2021Q4 sq Customer Funds Cash And Cash Equivalents
CustomerFundsCashAndCashEquivalents
2440941000 USD
CY2020Q4 sq Customer Funds Cash And Cash Equivalents
CustomerFundsCashAndCashEquivalents
1591308000 USD
CY2019Q4 sq Customer Funds Cash And Cash Equivalents
CustomerFundsCashAndCashEquivalents
438261000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6975090000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4793171000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1536967000 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, as well as related disclosure of contingent assets and liabilities. Actual results could differ from the Company’s estimates. To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be materially affected. The Company bases its estimates on current and past experience, to the extent that historical experience is predictive of future performance and other assumptions that the Company believes are reasonable under the circumstances. The Company evaluates these estimates on an ongoing basis.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimates, judgments, and assumptions in these consolidated financial statements include, but are not limited to, those related to accrued transaction losses, contingencies, valuation of loans held for sale, valuation of goodwill and acquired intangible assets, the determination of allowance for loan loss reserves for loans held for investment, pre-acquisition contingencies associated with business combinations, assessing the likelihood of adverse outcomes from claims and disputes, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accrued royalties, income and other taxes, operating and financing lease right-of-use assets and related liabilities, and share-based compensation.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">While the Company's business continues to be impacted by the COVID-19 pandemic, it experienced improvements in 2021 as compared to 2020, as the majority of U.S. markets transitioned to varying states of economic recovery and reopenings. However, the emergence of new and more transmissible variants of COVID-19 such as Delta and Omicron has led to a possible resurgence of the virus, particularly in populations with low vaccination rates, and has resulted in new restrictions in certain geographies and among certain businesses. The Company continues to monitor the carrying values of its assets and liabilities based on estimates, judgments and circumstances it is aware of and consider the effects and trends of COVID-19. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's estimates of accrued transaction losses and valuation of loans held for sale are based on historical experience, adjusted for market data relevant to the current economic environment including COVID-19 trends. The Company will continue to update its estimates as developments occur and additional information is obtained. See Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Fair Value of Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, for further details on amortized cost over fair value of the loans, and Note 11 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other Consolidated Balance Sheet Components (Current)</span>, for further details on transaction losses.
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
173110000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-606636000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3676735000 USD
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12995000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3256204000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1536967000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4793171000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
327630000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
95193000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
243401000 USD
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3841000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
670065000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
866902000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1536967000 USD
CY2021 us-gaap Advertising Expense
AdvertisingExpense
435800000 USD
CY2020 us-gaap Advertising Expense
AdvertisingExpense
224700000 USD
CY2019 us-gaap Advertising Expense
AdvertisingExpense
142700000 USD
CY2021 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
778300000 USD
CY2020 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
635300000 USD
CY2019 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
279700000 USD
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
25000000 USD
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
18300000 USD
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
23400000 USD
CY2021 us-gaap Interest Expense
InterestExpense
58100000 USD
CY2020 us-gaap Interest Expense
InterestExpense
75200000 USD
CY2019 us-gaap Interest Expense
InterestExpense
44900000 USD
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
18800000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
30300000 USD
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
71700000 USD
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
13500000 USD
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2021, 2020 and 2019, the Company had no customer that accounted for greater than 10% of total net revenue. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compa</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ny had two third-party payment processors that represented approximately 52% and 30% of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">settlements receivable as of December 31, 2021. As of December 31, 2020, there were two parties that represented approximately 59% and 27% of settlements receivable. All other third-party processors were insignificant. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, marketable debt securities, settlements receivable, customer funds, loans held for sale, and loans held for investment. The associated risk of concentration for cash and cash equivalents and restricted cash is mitigated by banking with creditworthy institutions. At certain times, amounts on deposit exceed federal deposit insurance limits. The associated risk of concentration for marketable debt securities is mitigated by holding a diversified portfolio of highly rated investments. Settlements receivable are amounts due from well-established payment processing companies and normally take <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc3MmYwMjFkMjE2MTQwZjFhZGI3OGFhYTZhMjcyZTJhL3NlYzo3NzJmMDIxZDIxNjE0MGYxYWRiNzhhYWE2YTI3MmUyYV85NC9mcmFnOjM4M2JiYmE5N2RhZjRiZjU5MmM1YzJiNzVlODk3YTNhL3RleHRyZWdpb246MzgzYmJiYTk3ZGFmNGJmNTkyYzVjMmI3NWU4OTdhM2FfMjQyMzU_2370c7b0-4784-4428-8b76-f5db3d62cf37">one</span> or <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjc3MmYwMjFkMjE2MTQwZjFhZGI3OGFhYTZhMjcyZTJhL3NlYzo3NzJmMDIxZDIxNjE0MGYxYWRiNzhhYWE2YTI3MmUyYV85NC9mcmFnOjM4M2JiYmE5N2RhZjRiZjU5MmM1YzJiNzVlODk3YTNhL3RleHRyZWdpb246MzgzYmJiYTk3ZGFmNGJmNTkyYzVjMmI3NWU4OTdhM2FfMjQyNDE_8c54f453-6d83-4370-9451-7d6d3b3dcd1e">two</span> business days to settle which mitigates the associated risk of concentration. The associated risk of concentration for loans held for sale is partially mitigated by credit evaluations that are performed prior to facilitating the offering of loans and ongoing performance monitoring of the Company’s loan customers. The risk associated with the PPP loans is considered low due to government guarantees on those loans.</span></div>
CY2021 sq Financing Receivable Reclassification From Held For Sale
FinancingReceivableReclassificationFromHeldForSale
224800000 USD
CY2021 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
39200000 USD
CY2020 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
42000000 USD
CY2021 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
33400000 USD
CY2020 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
19800000 USD
CY2019 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
18900000 USD
CY2021Q4 sq Asset Retirement Obligation Gross
AssetRetirementObligationGross
3800000 USD
CY2021 sq Business Combination Measurement Period
BusinessCombinationMeasurementPeriod
P1Y
CY2019 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
CY2020 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2021 us-gaap Revenues
Revenues
17661203000 USD
CY2020 us-gaap Revenues
Revenues
9497578000 USD
CY2019 us-gaap Revenues
Revenues
4713500000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
869525000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
869283000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
1536331000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
1526430000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2405856000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2395713000 USD
CY2021Q4 us-gaap Customer Funds
CustomerFunds
2830995000 USD
CY2020Q4 us-gaap Customer Funds
CustomerFunds
2037832000 USD
us-gaap Loans Receivable Held For Sale Reconciliation To Cash Flow Deductions From Held For Sale
LoansReceivableHeldForSaleReconciliationToCashFlowDeductionsFromHeldForSale
725900000 USD
CY2021 us-gaap Loans Receivable Held For Sale Reconciliation To Cash Flow Deductions From Held For Sale
LoansReceivableHeldForSaleReconciliationToCashFlowDeductionsFromHeldForSale
679600000 USD
CY2021Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
91400000 USD
CY2021 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
0 USD
CY2021Q4 us-gaap Financing Receivable Threshold Period Past Due
FinancingReceivableThresholdPeriodPastDue
P60D
CY2021Q4 us-gaap Financing Receivable Threshold Period Past Due
FinancingReceivableThresholdPeriodPastDue
P60D
CY2021Q4 us-gaap Financing Receivable Threshold Period Past Due
FinancingReceivableThresholdPeriodPastDue
P60D
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
541452000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
461641000 USD
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
259312000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
228121000 USD
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
282140000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
233520000 USD
CY2021 us-gaap Depreciation
Depreciation
94200000 USD
CY2020 us-gaap Depreciation
Depreciation
65000000 USD
CY2019 us-gaap Depreciation
Depreciation
60600000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
266345000 USD
CY2020 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
49571000 USD
CY2020 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
785000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
316701000 USD
CY2021 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
203079000 USD
CY2021 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
-504000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
519276000 USD
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q2 us-gaap Goodwill
Goodwill
295760000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
20079000 USD
us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
862000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
316701000 USD
CY2021 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
203079000 USD
CY2021 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
-504000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
519276000 USD
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
360087000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
103038000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
257049000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
202326000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
64714000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
137612000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
137612000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
69079000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
77102000 USD
CY2021 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
159100000 USD
CY2020 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
85960000 USD
CY2019 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
14559000 USD
CY2021 sq Amortizationof Acquired Intangible Assets
AmortizationofAcquiredIntangibleAssets
40522000 USD
CY2020 sq Amortizationof Acquired Intangible Assets
AmortizationofAcquiredIntangibleAssets
19239000 USD
CY2019 sq Amortizationof Acquired Intangible Assets
AmortizationofAcquiredIntangibleAssets
15000000 USD
CY2021 sq Finite Lived Intangible Assets Disposed Of By Sale
FiniteLivedIntangibleAssetsDisposedOfBySale
0 USD
CY2020 sq Finite Lived Intangible Assets Disposed Of By Sale
FiniteLivedIntangibleAssetsDisposedOfBySale
0 USD
CY2019 sq Finite Lived Intangible Assets Disposed Of By Sale
FiniteLivedIntangibleAssetsDisposedOfBySale
7582000 USD
CY2021 us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
859000 USD
CY2020 us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
1812000 USD
CY2019 us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
0 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
257049000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
137612000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
69079000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
83752000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
257049000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
42908000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
41657000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
38679000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
31852000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
18201000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
77058000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
61129000 USD
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
18778000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
30279000 USD
CY2021Q4 sq Processing Costs Receivable Current
ProcessingCostsReceivableCurrent
228914000 USD
CY2020Q4 sq Processing Costs Receivable Current
ProcessingCostsReceivableCurrent
148606000 USD
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
63341000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
34279000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
89702000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
41960000 USD
CY2021Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
91447000 USD
CY2020Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
0 USD
CY2021Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
118189000 USD
CY2020Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
66814000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
687429000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
383067000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
254900000 USD
CY2021 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
44400000 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
48462000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
44908000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
126710000 USD
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
53616000 USD
CY2020Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
0 USD
CY2021Q4 sq Accrued Transaction Losses
AccruedTransactionLosses
55167000 USD
CY2020Q4 sq Accrued Transaction Losses
AccruedTransactionLosses
70557000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
82173000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
47089000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
455000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
144536000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
71586000 USD
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
639309000 USD
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
360850000 USD
CY2021Q4 sq Nonmarketable Equity Securities Noncurrent
NonmarketableEquitySecuritiesNoncurrent
81919000 USD
CY2020Q4 sq Nonmarketable Equity Securities Noncurrent
NonmarketableEquitySecuritiesNoncurrent
32510000 USD
CY2021Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
0 USD
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
376258000 USD
CY2021Q4 sq Cryptocurrency Denominated Assets Noncurrent
CryptocurrencyDenominatedAssetsNoncurrent
149000000 USD
CY2020Q4 sq Cryptocurrency Denominated Assets Noncurrent
CryptocurrencyDenominatedAssetsNoncurrent
50000000 USD
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
71702000 USD
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
13526000 USD
CY2021Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
67914000 USD
CY2020Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
26956000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
370535000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
499250000 USD
CY2021 sq Nonmarketable Equity Securities Realized Gain Loss
NonmarketableEquitySecuritiesRealizedGainLoss
-12400000 USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
201000 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
114000 USD
CY2021 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
71100000 USD
CY2021Q4 sq Cryptocurrency Denominated Assets Noncurrent
CryptocurrencyDenominatedAssetsNoncurrent
149000000 USD
CY2021Q4 sq Statutory Liabilities Noncurrent
StatutoryLiabilitiesNoncurrent
133020000 USD
CY2020Q4 sq Statutory Liabilities Noncurrent
StatutoryLiabilitiesNoncurrent
75370000 USD
CY2021Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
89826000 USD
CY2020Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
9921000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
222846000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
85291000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
417356000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
369016000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
456335000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-259894000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-153049000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-78122000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
157462000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
215967000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
378213000 USD
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3186000 USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4016000 USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
930000 USD
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
5684000 USD
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
6862000 USD
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
3099000 USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
9071000 USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
10878000 USD
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4143000 USD
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1463000 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-970000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-777000 USD
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-524000 USD
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-231000 USD
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-399000 USD
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-8448000 USD
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-6815000 USD
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-200000 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10435000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-8016000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1376000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1364000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2862000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2767000 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.006
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.003
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.001
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.104
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.040
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.014
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.054
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.027
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.005
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.839
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.346
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.139
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.016
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.022
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.005
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
2.904
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
1.539
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.349
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-2.750
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-1.554
CY2019 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.458
CY2021 sq Effective Income Tax Rate Reconciliation Change In Uncertain Tax Positions Percent
EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositionsPercent
0.050
CY2020 sq Effective Income Tax Rate Reconciliation Change In Uncertain Tax Positions Percent
EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositionsPercent
0.023
CY2019 sq Effective Income Tax Rate Reconciliation Change In Uncertain Tax Positions Percent
EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositionsPercent
0.005
CY2021 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
0.012
CY2021 sq Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent
0.059
CY2020 sq Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent
0.036
CY2019 sq Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent
0.006
CY2021 sq Effective Income Tax Rate Reconciliation Nondeductible Expense Acquisition Related Costs Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionRelatedCostsPercent
0.059
CY2020 sq Effective Income Tax Rate Reconciliation Nondeductible Expense Acquisition Related Costs Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionRelatedCostsPercent
0.013
CY2019 sq Effective Income Tax Rate Reconciliation Nondeductible Expense Acquisition Related Costs Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionRelatedCostsPercent
0.007
CY2021 sq Effective Income Tax Rate Reconciliation Intercompany Transactions Percent
EffectiveIncomeTaxRateReconciliationIntercompanyTransactionsPercent
0.038
CY2020 sq Effective Income Tax Rate Reconciliation Intercompany Transactions Percent
EffectiveIncomeTaxRateReconciliationIntercompanyTransactionsPercent
0
CY2019 sq Effective Income Tax Rate Reconciliation Intercompany Transactions Percent
EffectiveIncomeTaxRateReconciliationIntercompanyTransactionsPercent
0
CY2021 sq Effective Income Tax Rate Reconciliation Debt Income Cancellation Percent
EffectiveIncomeTaxRateReconciliationDebtIncomeCancellationPercent
0.080
CY2020 sq Effective Income Tax Rate Reconciliation Debt Income Cancellation Percent
EffectiveIncomeTaxRateReconciliationDebtIncomeCancellationPercent
0
CY2019 sq Effective Income Tax Rate Reconciliation Debt Income Cancellation Percent
EffectiveIncomeTaxRateReconciliationDebtIncomeCancellationPercent
0
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.009
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.013
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.007
CY2021Q4 sq Deferred Tax Assets Capitalized Expenses
DeferredTaxAssetsCapitalizedExpenses
12409000 USD
CY2020Q4 sq Deferred Tax Assets Capitalized Expenses
DeferredTaxAssetsCapitalizedExpenses
17994000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
62707000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
47653000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1276561000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
962069000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
378682000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
254789000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
50431000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
40784000 USD
CY2021Q4 sq Deferred Tax Asset Deferred Interest
DeferredTaxAssetDeferredInterest
34475000 USD
CY2020Q4 sq Deferred Tax Asset Deferred Interest
DeferredTaxAssetDeferredInterest
13800000 USD
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
7740000 USD
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
0 USD
CY2021Q4 sq Deferred Tax Assets Operating Lease Net
DeferredTaxAssetsOperatingLeaseNet
111099000 USD
CY2020Q4 sq Deferred Tax Assets Operating Lease Net
DeferredTaxAssetsOperatingLeaseNet
107542000 USD
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
17600000 USD
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
11266000 USD
CY2020Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
0 USD
CY2021Q4 sq Deferred Tax Asset Debt Instrument
DeferredTaxAssetDebtInstrument
70316000 USD
CY2020Q4 sq Deferred Tax Asset Debt Instrument
DeferredTaxAssetDebtInstrument
277000 USD
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2033286000 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1444908000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1887111000 USD
CY2020Q4 sq Deferred Tax Liabilities Property Equipmentand Intangible Assets
DeferredTaxLiabilitiesPropertyEquipmentandIntangibleAssets
12784000 USD
CY2021Q4 sq Deferred Tax Liabilities Indefinitelived Intangible Asset
DeferredTaxLiabilitiesIndefinitelivedIntangibleAsset
867000 USD
CY2020Q4 sq Deferred Tax Liabilities Indefinitelived Intangible Asset
DeferredTaxLiabilitiesIndefinitelivedIntangibleAsset
352000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1238010000 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
146175000 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
206898000 USD
CY2021Q4 sq Deferred Tax Liabilities Property Equipmentand Intangible Assets
DeferredTaxLiabilitiesPropertyEquipmentandIntangibleAssets
31775000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
1392000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
4712000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
73425000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
108747000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
111167000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
146101000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
199120000 USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
74000 USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
7778000 USD
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
649100000 USD
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
378400000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
448400000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
35400000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
295182000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
217574000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
198540000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
6552000 USD
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
2615000 USD
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
11571000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
124238000 USD
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
77235000 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
30676000 USD
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0 USD
CY2020 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
49000 USD
CY2021 sq Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Share Based Compensation Plans
SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofShareBasedCompensationPlans
2 plan
CY2019 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
149000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Acquisition
UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
22420000 USD
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Acquisition
UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
3037000 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Acquisition
UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
78000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
448392000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
295182000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
217574000 USD
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
7800000 USD
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
1400000 USD
CY2019 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
500000 USD
CY2021Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
100000 USD
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0000001
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019 sq Recovery Of Shares Issued And Withheld For Indemnification Purposes Shares
RecoveryOfSharesIssuedAndWithheldForIndemnificationPurposesShares
20793 shares
CY2021 sq Recovery Of Shares Issued And Withheld For Indemnification Purposes Shares
RecoveryOfSharesIssuedAndWithheldForIndemnificationPurposesShares
0 shares
CY2020 sq Recovery Of Shares Issued And Withheld For Indemnification Purposes Shares
RecoveryOfSharesIssuedAndWithheldForIndemnificationPurposesShares
0 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2723394000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13630882 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.84
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M2D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
198771 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
255.22
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4900413 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.33
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
13140 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
67.50
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8916100 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.09
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M20D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1226105000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
7769686 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
16.58
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y3M18D
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1129046000 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1100000000 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1200000000 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
616300000 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
131.57
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
27.04
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
30.58
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
608042000 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
397500000 USD
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
297863000 USD
CY2021 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
15100000 USD
CY2020 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
13900000 USD
CY2019 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
8200000 USD
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1700000000 USD
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M18D
CY2021 us-gaap Profit Loss
ProfitLoss
158826000 USD
CY2020 us-gaap Profit Loss
ProfitLoss
213105000 USD
CY2019 us-gaap Profit Loss
ProfitLoss
375446000 USD
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-7458000 USD
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1953000 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
166284000 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
166284000 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
213105000 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
213105000 USD
CY2019 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
375446000 USD
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
375446000 USD
CY2021 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
458780000 shares
CY2020 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
443773000 shares
CY2019 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
425728000 shares
CY2021 sq Weighted Average Numberof Shares Unvested Shares
WeightedAverageNumberofSharesUnvestedShares
348000 shares
CY2020 sq Weighted Average Numberof Shares Unvested Shares
WeightedAverageNumberofSharesUnvestedShares
647000 shares
CY2019 sq Weighted Average Numberof Shares Unvested Shares
WeightedAverageNumberofSharesUnvestedShares
729000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
458432000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
443126000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
424999000 shares
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
17849000 shares
CY2020 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
23628000 shares
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
30645000 shares
CY2021 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
408000 shares
CY2019 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2021 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
25090000 shares
CY2020 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
15413000 shares
CY2019 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
10432000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
501779000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
482167000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
466076000 shares
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
48898000 shares
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
59722000 shares
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
54885000 shares
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
0 USD
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
83136000 USD
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
70254000 USD
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
15568000 USD
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
15625000 USD
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
6375000 USD
CY2021 us-gaap Sublease Income
SubleaseIncome
12210000 USD
CY2020 us-gaap Sublease Income
SubleaseIncome
8594000 USD
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0 USD
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2446000 USD
CY2021 us-gaap Lease Cost
LeaseCost
88447000 USD
CY2020 us-gaap Lease Cost
LeaseCost
86106000 USD
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y3M18D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.04
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
77201000 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
46901000 USD
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 USD
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2446000 USD
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
63290000 USD
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
342662000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
78304000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
77904000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
59612000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
53839000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
46015000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
224498000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
540172000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
76407000 USD
CY2021Q4 sq Lessee Operating Lease Liability Lease Not Yet Commenced
LesseeOperatingLeaseLiabilityLeaseNotYetCommenced
0 USD
CY2021Q4 sq Lessee Operating Lease Lease Incentive Payable And Transfer To Held For Sale
LesseeOperatingLeaseLeaseIncentivePayableAndTransferToHeldForSale
4721000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
459044000 USD
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
80300000 USD
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
75200000 USD
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
32500000 USD
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2021 us-gaap Revenues
Revenues
17661203000 USD
CY2020 us-gaap Revenues
Revenues
9497578000 USD
CY2019 us-gaap Revenues
Revenues
4713500000 USD
CY2021 us-gaap Gross Profit
GrossProfit
4419823000 USD
CY2020 us-gaap Gross Profit
GrossProfit
2733409000 USD
CY2019 us-gaap Gross Profit
GrossProfit
1889685000 USD
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
1507871000 USD
CY2020 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1399079000 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
885681000 USD
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
674165000 USD
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1617189000 USD
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1109670000 USD
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
625126000 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
983326000 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
579203000 USD
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
436878000 USD
CY2021 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
187991000 USD
CY2020 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
177670000 USD
CY2019 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
126959000 USD
CY2021 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
71126000 USD
CY2020 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2019 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2021 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 USD
CY2019 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
373445000 USD
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-33124000 USD
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-56943000 USD
CY2019 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-21516000 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
29474000 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
291725000 USD
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-273000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
157462000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
215967000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
378213000 USD
CY2021 us-gaap Revenues
Revenues
17661203000 USD
CY2020 us-gaap Revenues
Revenues
9497578000 USD
CY2019 us-gaap Revenues
Revenues
4713500000 USD
CY2020Q4 us-gaap Noncurrent Assets
NoncurrentAssets
1144721000 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
40446000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
3857000 USD
CY2019 us-gaap Interest Paid Net
InterestPaidNet
5677000 USD
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
10041000 USD
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
6001000 USD
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
2744000 USD
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
63290000 USD
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
342662000 USD
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
40555000 USD
CY2021 sq Changein Capital Expenditures Incurredbut Notyet Paid
ChangeinCapitalExpendituresIncurredbutNotyetPaid
15071000 USD
CY2020 sq Changein Capital Expenditures Incurredbut Notyet Paid
ChangeinCapitalExpendituresIncurredbutNotyetPaid
-3975000 USD
CY2019 sq Changein Capital Expenditures Incurredbut Notyet Paid
ChangeinCapitalExpendituresIncurredbutNotyetPaid
-419000 USD
CY2021 sq Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Unpaid Purchase Price
NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationUnpaidPurchasePrice
50079000 USD
CY2019 sq Other Significant Noncash Transaction Fair Value Of Shares Received To Settle Derivatives
OtherSignificantNoncashTransactionFairValueOfSharesReceivedToSettleDerivatives
0 USD
CY2020 sq Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Unpaid Purchase Price
NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationUnpaidPurchasePrice
8974000 USD
CY2019 sq Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Unpaid Purchase Price
NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationUnpaidPurchasePrice
8411000 USD
CY2021 sq Noncash Proceeds From Disposal Group
NoncashProceedsFromDisposalGroup
0 USD
CY2020 sq Noncash Proceeds From Disposal Group
NoncashProceedsFromDisposalGroup
0 USD
CY2019 sq Noncash Proceeds From Disposal Group
NoncashProceedsFromDisposalGroup
100000000 USD
CY2021 sq Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Value
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValue
28735000 USD
CY2020 sq Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Value
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValue
35318000 USD
CY2019 sq Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Value
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValue
0 USD
CY2021 sq Noncash Recovery Of Shares Issued And Withheld For Indemnification Purposes
NoncashRecoveryOfSharesIssuedAndWithheldForIndemnificationPurposes
0 USD
CY2020 sq Noncash Recovery Of Shares Issued And Withheld For Indemnification Purposes
NoncashRecoveryOfSharesIssuedAndWithheldForIndemnificationPurposes
0 USD
CY2019 sq Noncash Recovery Of Shares Issued And Withheld For Indemnification Purposes
NoncashRecoveryOfSharesIssuedAndWithheldForIndemnificationPurposes
789000 USD
CY2021 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1258562000 USD
CY2020 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1398829000 USD
CY2019 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
CY2021 sq Other Significant Noncash Transaction Fair Value Of Shares Received To Settle Derivatives
OtherSignificantNoncashTransactionFairValueOfSharesReceivedToSettleDerivatives
1800933000 USD
CY2020 sq Other Significant Noncash Transaction Fair Value Of Shares Received To Settle Derivatives
OtherSignificantNoncashTransactionFairValueOfSharesReceivedToSettleDerivatives
369015000 USD
CY2021 sq Transfer Of Cryptocurrency Denominated Assets To Third Party Borrowers
TransferOfCryptocurrencyDenominatedAssetsToThirdPartyBorrowers
-6084000 USD
CY2020 sq Transfer Of Cryptocurrency Denominated Assets To Third Party Borrowers
TransferOfCryptocurrencyDenominatedAssetsToThirdPartyBorrowers
0 USD
CY2019 sq Transfer Of Cryptocurrency Denominated Assets To Third Party Borrowers
TransferOfCryptocurrencyDenominatedAssetsToThirdPartyBorrowers
0 USD

Files In Submission

Name View Source Status
0001628280-22-003825-index-headers.html Edgar Link pending
0001628280-22-003825-index.html Edgar Link pending
0001628280-22-003825.txt Edgar Link pending
0001628280-22-003825-xbrl.zip Edgar Link pending
exhibit1021blockinc2021.htm Edgar Link pending
exhibit1021blockinc2021a.htm Edgar Link pending
exhibit1022blockinc2021.htm Edgar Link pending
exhibit1023blockinc2021.htm Edgar Link pending
exhibit1024blockinc2021.htm Edgar Link pending
exhibit103blockinc2021.htm Edgar Link pending
exhibit106blockinc2021.htm Edgar Link pending
exhibit108blockinc2021.htm Edgar Link pending
exhibit211blockinc2021.htm Edgar Link pending
exhibit231blockinc2021.htm Edgar Link pending
exhibit311blockinc2021.htm Edgar Link pending
exhibit312blockinc2021.htm Edgar Link pending
exhibit31blockinc2021.htm Edgar Link pending
exhibit321blockinc2021.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_0a.jpg Edgar Link pending
image_2a.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sq-20211231.htm Edgar Link pending
sq-20211231.xsd Edgar Link pending
sq-20211231_cal.xml Edgar Link unprocessable
sq-20211231_def.xml Edgar Link unprocessable
sq-20211231_g1.jpg Edgar Link pending
sq-20211231_g2.jpg Edgar Link pending
sq-20211231_g3.jpg Edgar Link pending
sq-20211231_htm.xml Edgar Link completed
sq-20211231_lab.xml Edgar Link unprocessable
sq-20211231_pre.xml Edgar Link unprocessable